BioN­Tech opens new plas­mid DNA man­u­fac­tur­ing fa­cil­i­ty in Ger­many

Ger­man mR­NA play­er BioN­Tech opened the doors to a new man­u­fac­tur­ing fa­cil­i­ty on Thurs­day, this one just about 75 miles north of its head­quar­ters in Mainz, Ger­many.

BioN­Tech an­nounced on Thurs­day that it has com­plet­ed the con­struc­tion of its first plas­mid DNA man­u­fac­tur­ing fa­cil­i­ty in Mar­burg, Ger­many. The fa­cil­i­ty will pro­duce ma­te­ri­als for mR­NA-based vac­cines and ther­a­pies along with cell ther­a­pies.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER